News
For Airlines, Dry Ice in Vaccine Transport Demands Special Attention
The large amounts of dry ice needed to speed Covid-19 vaccine candidates to pandemic-weary populations will call for special attention from airlines and safety regulators.
Dry ice, the solid form of carbon dioxide, is a critical part of plans to...
News
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
The ongoing synergy from the Covance consolidation is a major plus. However, a challenging volume environment for testing laboratories and softness in utilization are headwinds for LabCorp.
Year to date, shares of LabCorp have improved 17.6% compared with the industry’s...
News
COVID-19 vaccine: After Pfizer, SII, Bharat Biotech seeks emergency use authorisation for its Covaxin
Bharat Biotech had applied to the Drugs Controller General of India seeking emergency use authorisation for its Covid-19 vaccine Covaxin. The Pune-based Serum Institute of India (SII) had applied to the central drug regulator for emergency use authorisation of...
News
Sheremetyevo International handles Sputnik V vaccine shipment
Sheremetyevo International Airport was the launching point for an early batch of Russian Covid-19 vaccine Sputnik V. In total, 20 doses of the vaccine were transported from Moscow to Serbia where it will be used in clinical trials at...
Clinical Trials
Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results from Eli Lilly and Company's SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety...
News
Merck Expands Life Science Production Capacities in the United States
Merck, a leading science and technology company, announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to...
News
Aizon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing
Based on its recent analysis of the North American artificial intelligence (AI) market for productivity and compliance in pharmaceuticals, Frost & Sullivan recognizes Aizon with the 2020 North American Enabling Technology Leadership Award. Aizon's good practice (GxP)-compliant, cloud-based, and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read